A Novel Serum Bilirubin-Inclusive Model Predicts Kidney Failure in CKD

Overview

This study developed and validated a new predictive model for progression to end-stage kidney disease (ESKD) in chronic kidney disease (CKD) patients, incorporating serum bilirubin levels as a key predictor. The model demonstrated excellent discrimination and calibration in both development and validation cohorts, outperforming existing models.

Background

Chronic kidney disease is a growing global health concern with high risks of cardiovascular events and progression to ESKD. Existing prediction models, such as the Kidney Failure Risk Equations (KFREs), use variables like age, gender, eGFR, and albuminuria but have limitations in predictive performance. Oxidative stress contributes to CKD progression, and bilirubin, a potent antioxidant, has been inversely associated with CKD progression. However, prior prediction models have not incorporated serum bilirubin levels.

Data Highlights

Key Findings

• Serum bilirubin levels emerged as a strong and independent predictor of progression from CKD to ESKD.
• The final predictive model included nine variables: eGFR, serum bilirubin, proteinuria, age, diabetes, gender, hypertension, serum albumin, and hemoglobin.
• The model showed excellent discrimination with time-dependent AUCs of 0.943 at 2 years and 0.935 at 5 years in the validation cohort.
• The model demonstrated excellent calibration, indicating accurate risk estimation across different risk levels.
• Incorporation of serum bilirubin improved predictive performance beyond traditional KFRE variables.

Clinical Implications

Incorporating serum bilirubin into risk prediction models may enhance clinicians' ability to identify CKD patients at high risk for progression to ESKD. This improved prediction can guide timely interventions and personalized management strategies. Routine measurement of serum bilirubin could be considered in CKD risk stratification protocols.

Conclusion

Serum bilirubin is a robust predictor of CKD progression to ESKD, and its inclusion in a novel predictive model significantly improves risk stratification accuracy. This model offers a valuable tool for clinical decision-making in CKD management.

References

1. Kyushu University Hospital Study 2008-2018 -- Novel ESKD Prediction Model Incorporating Serum Bilirubin
2. Tangri et al. -- Kidney Failure Risk Equations